Specific Membrane Receptor Gene Expression Targeted With Radiolabeled Peptide Employing the erbB-2 and DF3 Promoter Elements in Adenoviral Vectors

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700049
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Enhanced Peptide of Prostate Cancer Using Targeted Adenoviral Vectors

2005English

Prolactinoma ErbB Receptor Expression and Targeted Therapy for Aggressive Tumors

Endocrine
2013English

Induction of Human Somatostatin Receptor Subtype 2 on Breast Tumors With an Adenoviral Vector for Their Treatment and Detection With a Radiolabeled Peptide

2002English

Targeted Overexpression of Androgen Receptor With a Liver-Specific Promoter in Transgenic Mice.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Cell Cycle-Specific Changes in hTERT Promoter Activity in Normal and Cancerous Cells in Adenoviral Gene Therapy: A Promising Implication of Telomerase-Dependent Targeted Cancer Gene Therapy

International Journal of Oncology
Cancer ResearchOncology
2006English

Antibodies Targeted to TRAIL Receptor-2 and ErbB-2 Synergize in Vivo and Induce an Antitumor Immune Response

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Dissecting Promoter of InMYB1 Gene Showing Petal-Specific Expression

Plant Biotechnology
BiotechnologyAgronomyPlant ScienceCrop Science
2018English

Retroviral Vectors Preloaded With a Viral Receptor-Ligand Bridge Protein Are Targeted to Specific Cell Types

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Helper‐Dependent Adenoviral Vectors

2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy